Artificial intelligence in histopathology: enhancing cancer research and clinical oncology

A Shmatko, N Ghaffari Laleh, M Gerstung, JN Kather - Nature cancer, 2022 - nature.com
Artificial intelligence (AI) methods have multiplied our capabilities to extract quantitative
information from digital histopathology images. AI is expected to reduce workload for human …

Deep learning in cancer diagnosis, prognosis and treatment selection

KA Tran, O Kondrashova, A Bradley, ED Williams… - Genome Medicine, 2021 - Springer
Deep learning is a subdiscipline of artificial intelligence that uses a machine learning
technique called artificial neural networks to extract patterns and make predictions from …

Deep learning in histopathology: the path to the clinic

J Van der Laak, G Litjens, F Ciompi - Nature medicine, 2021 - nature.com
Abstract Machine learning techniques have great potential to improve medical diagnostics,
offering ways to improve accuracy, reproducibility and speed, and to ease workloads for …

Deep learning in cancer pathology: a new generation of clinical biomarkers

A Echle, NT Rindtorff, TJ Brinker, T Luedde… - British journal of …, 2021 - nature.com
Clinical workflows in oncology rely on predictive and prognostic molecular biomarkers.
However, the growing number of these complex biomarkers tends to increase the cost and …

Swarm learning for decentralized artificial intelligence in cancer histopathology

OL Saldanha, P Quirke, NP West, JA James… - Nature medicine, 2022 - nature.com
Artificial intelligence (AI) can predict the presence of molecular alterations directly from
routine histopathology slides. However, training robust AI systems requires large datasets …

Deep learning with radiomics for disease diagnosis and treatment: challenges and potential

X Zhang, Y Zhang, G Zhang, X Qiu, W Tan, X Yin… - Frontiers in …, 2022 - frontiersin.org
The high-throughput extraction of quantitative imaging features from medical images for the
purpose of radiomic analysis, ie, radiomics in a broad sense, is a rapidly developing and …

Colorectal cancer organoid–stroma biobank allows subtype-specific assessment of individualized therapy responses

HF Farin, MH Mosa, B Ndreshkjana, BM Grebbin… - Cancer discovery, 2023 - AACR
In colorectal cancers, the tumor microenvironment plays a key role in prognosis and therapy
efficacy. Patient-derived tumor organoids (PDTO) show enormous potential for preclinical …

Phenotypic plasticity and genetic control in colorectal cancer evolution

J Househam, T Heide, GD Cresswell, I Spiteri… - Nature, 2022 - nature.com
Genetic and epigenetic variation, together with transcriptional plasticity, contribute to
intratumour heterogeneity. The interplay of these biological processes and their respective …

[HTML][HTML] Gastrointestinal cancer classification and prognostication from histology using deep learning: Systematic review

S Kuntz, E Krieghoff-Henning, JN Kather, T Jutzi… - European Journal of …, 2021 - Elsevier
Background Gastrointestinal cancers account for approximately 20% of all cancer diagnoses
and are responsible for 22.5% of cancer deaths worldwide. Artificial intelligence–based …

Artificial intelligence to identify genetic alterations in conventional histopathology

D Cifci, S Foersch, JN Kather - The Journal of Pathology, 2022 - Wiley Online Library
Precision oncology relies on the identification of targetable molecular alterations in tumor
tissues. In many tumor types, a limited set of molecular tests is currently part of standard …